78 results
424B5
ENVB
Enveric Biosciences Inc
11 Mar 24
Prospectus supplement for primary offering
12:35pm
of RIFFIT, Inc.; Professor, St. George’s University of London
Clinical Research
John Krystal, M.D.
Director of Yale Center for Clinical Investigation
8-K
EX-10.1
ENVB
Enveric Biosciences Inc
11 Mar 24
Entry into a Material Definitive Agreement
8:00am
of Common Stock of the Company are listed for trading on Nasdaq. Except as set forth in the SEC Reports, there is no suit, action, proceeding or investigation … ’ fees and costs of investigation, that any such Investor Party may suffer or incur (the “Indemnified Liabilities”) as a result of or relating to any
8-K
EX-4.1
ENVB
Enveric Biosciences Inc
29 Dec 23
Entry into a Material Definitive Agreement
4:43pm
be reimbursed by the other party for their reasonable attorneys’ fees and other costs and expenses incurred with the investigation, preparation
8-K
EX-10.2
822cchjl jdz47
6 Nov 23
Entry into a Material Definitive Agreement
8:05am
8-K
EX-10.1
hr90qo zw1ubeo
6 Nov 23
Entry into a Material Definitive Agreement
8:05am
8-K
EX-5.1
1s3d4ygqdol8rk950u
1 Sep 23
Entry into a Material Definitive Agreement
5:26pm
8-K
EX-1.1
88h8fw7ilxx 2l7q8t
1 Sep 23
Entry into a Material Definitive Agreement
5:26pm
8-K
EX-10.3
c81xe
26 Jul 22
Enveric Biosciences Announces $8 Million Registered Direct Offering and Private Placement, Priced at a Premium to Market Under Nasdaq Rules
5:15pm
8-K
EX-10.2
1qb 2s0qgi7e
26 Jul 22
Enveric Biosciences Announces $8 Million Registered Direct Offering and Private Placement, Priced at a Premium to Market Under Nasdaq Rules
5:15pm
8-K
EX-10.1
n094 e7y5
26 Jul 22
Enveric Biosciences Announces $8 Million Registered Direct Offering and Private Placement, Priced at a Premium to Market Under Nasdaq Rules
5:15pm
8-K
EX-99.1
dtue6y
19 Jul 22
Enveric Biosciences Announces Formation of Scientific Advisory Board to Drive Further Growth of Next-Generation Mental Health Medicines
8:25am
8-K
EX-10.1
6qqtughw
11 May 22
Enveric Biosciences Announces Plans to Spin-off and Dividend its Cannabinoid Pipeline to Shareholders
1:46pm
8-K
EX-10.3
th0wnh8
11 May 22
Enveric Biosciences Announces Plans to Spin-off and Dividend its Cannabinoid Pipeline to Shareholders
1:46pm